
GC73928
BDM19
Also known as 4-[6-iodo-2-[(E)-2-(3-methylphenyl)ethenyl]-4-oxoquinazolin-3-yl]benzoic acid
BDM19 binds and activates cytosolic BAX dimers, and prompts cell apoptosis either alone or in combination with BCL-2/BCL-XL inhibitor Navitoclax
ChemicalCAS500273-31-4MW508.31FormulaC24H17IN2O3
- CAS number
- 500273-31-4
- Molecular weight
- 508.31
- Formula
- C24H17IN2O3
- Solubility
- DMSO : 100 mg/mL (196·73 mM; Need ultrasonic)
- InChIKey
- CQEADRMBOXGOAE-LFYBBSHMSA-N
- Catalogue number
- GC73928
- Brand
- GLPBIO
Computed properties PubChem CID 6105914 · XLogP 5.1 · TPSA 70 Ų · H-bond donors 1
- XLogP
- 5.1
- TPSA
- 70 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 30
SMILES CC1=CC(=CC=C1)/C=C/C2=NC3=C(C=C(C=C3)I)C(=O)N2C4=CC=C(C=C4)C(=O)O
Computed descriptors from PubChem (CID 6105914), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il